kezar life sciences share price
KZR stock quote history news and other vital information to help you with your stock trading and investing. These price ends are -9608 and -23183 off the current price level respectively although investors could be excited at the prospect of a -17903 if the KZR share price touches on the median price of 1850.
5 Simple Things You Should Do For A Happy Marriage Best Marriage Advice Ever Youtube Happy Marriage Good Marriage Best Marriage Advice
Kezar Announces Topline Results from PRESIDIO Trial of Zetomipzomib for the Treatment of Dermatomyositis and Polymyositis.
. 073 1101 NASDAQ. Days Range 522 - 547 Revenue NA Open 54 52 wk Range 22 - 967 EPS - 125 Volume 118098 Market Cap 24615M Dividend Yield NA NA Average. Kezar Life Sciences Inc.
Kezar Life Sciences KZR stock price charts trades the USs most popular discussion forums. Kezar is translating its innovative research on the immunoproteasome and protein secretion pathways to advance novel therapeutic approaches. About Kezar Life Sciences.
Key Stock Data PE Ratio TTM NA EPS TTM -104 Market Cap 32383 M. View our latest analysis for Kezar Life Sciences. Get the latest Kezar Life Sciences stock price and detailed information including KZR news historical charts and realtime prices.
No significant news for KZR in the past two years. Free forex prices toplists indices and lots more. Kezar Life Sciences NASDAQKZR Get Rating last issued its earnings results on Thursday May 12thThe company reported 026 earnings per share EPS for the quarter topping analysts.
Kezar Life Sciences KZR share price charts trades the UKs most popular discussion forums. The company is forecast to post a net loss per share of US124 next year compared to a net loss per share of US104 last year. A high-level overview of Kezar Life Sciences Inc.
Capital Com Australia Limited Australia Regulated by ASIC Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority FCA Capital Com SV Investments Limited Cyprus EU Regulated by CYSEC Capital Com Bel Belarus Regulated by NBRB Our Global Offices. Common Stock KZR Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. Historical Quotes Analyst Estimates Options Key Data Open 868 Day Range 788 - 876 52 Week Range 461 - 1855 Market Cap 6987M Shares Outstanding 5671M Public Float 4771M Beta 094 Rev.
News Kezar Life Sciences Inc. The analyst consensus target price for shares in Kezar Life Sciences is 2200. View Kezar Life Sciences stock share price financial statements key ratios and more at Craft.
Stock is up 17 over the past year. Price USD 1188 Todays Change -022 -182 Shares traded 69638k 1 Year change 10733 Beta 04299 Data delayed at least 15 minutes as of Apr 29 2022 2100 BST. Take Action Add this security.
Take Action Add this security to. New target price is 220 above last closing price of US645. Coming back to Kezar Life Sciences Inc.
Kezar Life Sciences market cap is 7235 m. Price EUR 1370 Todays Change 0600 458 Shares traded 18300 1 Year change 17621 Beta -- Data delayed at least 15 minutes as of Mar 18 2022 0701 BST. Kezar Life Sciences Inc KZR USD0001 Sell.
Find the latest Kezar Life Sciences Inc. That means that an insider was happy to buy shares at around the current. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.
KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders today announced. Down from US2267 the current price target is an average from 5 analysts. The Last 12 Months Of Insider Transactions At Kezar Life Sciences.
On average they anticipate Kezar Life Sciences stock price to reach 1667 in the next year. SOUTH SAN FRANCISCO Calif May 03 2022--Kezar Life Sciences Inc Nasdaq. Their forecasts range from 1400 to 2200.
Free forex prices toplists indices and lots more. Stock analysis for Kezar Life Sciences Inc KZRNASDAQ GS including stock price stock chart company news key statistics fundamentals and company profile. NASDAQKZR we note that the average 3-month trading volume was 95098K.
Analysts covering Kezar Life Sciences currently have a consensus Earnings Per Share EPS forecast of -130 for the next financial year. 3 brokers have issued 12-month price targets for Kezar Life Sciences shares. Based in South San Francisco Kezar Life Sciences is a clinical-stage biotechnology company committed to revolutionizing treatments for patients with autoimmune diseases and cancer.
Over the last year we can see that the biggest insider purchase was by Director Franklin Berger for US750k worth of shares at about US1500 per share. That is 3447 above the last closing price of 1636.
Top 5 Insider Purchases For March 22 2022 In 2022 Life Science Company Symbol Biotechnology
Pin On What S Going On
Pin On Travel
Pin On Wheel Of The Year
Yearbookyourself Give Your Photos 1950s 60s 70s Look Yearbook Yourself Yearbook Pictures Yearbook
Oakland Raiders Frank Youell Field Laney College Oakland San Francisco Oakland Raiders Football Oakland California
Mechanical Heart Tattoo Best Tattoo Design Ideas Tattoos For Guys Badass Tattoos For Guys Badass Tattoos
Oh Robert Robert Plant Led Zeppelin Led Zeppelin Robert Plant
Top 5 Insider Purchases For March 22 2022 In 2022 Life Science Company Symbol Biotechnology
Pin On Travel
Pin On Texas Agriculture